CynergisTek (NYSEAMERICAN:CTEK) Downgraded by Zacks Investment Research to “Hold”
According to Zacks, “CynergisTek, Inc. provides cyber security and information management consulting in healthcare industry. It specializes in privacy, security, compliance and document management. The company’s service includes risk assessment, technical security, baseline security, information security program assessment, print security, vulnerability, architecture, penetration testing, social engineering and phishing and riskSonar assessment tool. CynergisTek Inc., formerly known as Auxilio, Inc., is headquartered in Mission Viejo, CA. “
Separately, TheStreet cut CynergisTek from a c- rating to a d rating in a research report on Monday, November 11th.
CynergisTek (NYSEAMERICAN:CTEK) last announced its quarterly earnings results on Monday, November 11th. The company reported ($0.07) EPS for the quarter. The company had revenue of $4.77 million for the quarter, compared to analyst estimates of $5.14 million.
Large investors have recently added to or reduced their stakes in the stock. King Luther Capital Management Corp raised its stake in CynergisTek by 10.1% in the 4th quarter. King Luther Capital Management Corp now owns 443,880 shares of the company’s stock worth $1,465,000 after purchasing an additional 40,568 shares in the last quarter. Essex Investment Management Co. LLC grew its position in shares of CynergisTek by 3.7% during the 4th quarter. Essex Investment Management Co. LLC now owns 151,945 shares of the company’s stock worth $501,000 after purchasing an additional 5,445 shares in the last quarter. Connors Investor Services Inc. grew its position in shares of CynergisTek by 23.3% during the 3rd quarter. Connors Investor Services Inc. now owns 71,450 shares of the company’s stock worth $220,000 after purchasing an additional 13,500 shares in the last quarter. BlackRock Inc. increased its holdings in shares of CynergisTek by 21.0% during the second quarter. BlackRock Inc. now owns 27,501 shares of the company’s stock worth $133,000 after purchasing an additional 4,771 shares during the period. Finally, Morgan Stanley increased its holdings in shares of CynergisTek by 208.0% during the second quarter. Morgan Stanley now owns 5,135 shares of the company’s stock worth $25,000 after purchasing an additional 3,468 shares during the period.
Cynergistek, Inc provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program.
Featured Story: Coverage Ratio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.